Current Affairs - August 2022 NBCC signed a pact with the MEA to redevelop a housing complex for how much? Rs.85 Crore Rs.114 Crore Rs.100 Crore Rs.175 Crore Rs.85 Crore Rs.114 Crore Rs.100 Crore Rs.175 Crore ANSWER EXPLANATION DOWNLOAD EXAMIANS APP NBCC Ltd has signed an agreement with the External Affairs Ministry to redevelop a housing complex in central Delhi for Rs 175 crore.
Current Affairs - August 2022 DRDO successfully tested the Pinaka Extended range rocket in which state? Pradesh Karnataka Rajasthan Odisha Pradesh Karnataka Rajasthan Odisha ANSWER EXPLANATION DOWNLOAD EXAMIANS APP Pinaka extended range rocket test fired from Rajasthan's Pokhran.
Current Affairs - August 2022 Who has become the first Indian footballer to play at the UEFA Women's Champions League 2022? Manisha Panna Pyari Xaxa Manisha Kalyan Aditi Chauhan Manisha Panna Pyari Xaxa Manisha Kalyan Aditi Chauhan ANSWER EXPLANATION DOWNLOAD EXAMIANS APP Manisha Kalyan has become the first Indian footballer to play at the UEFA Women's Champions League 2022.
Current Affairs - August 2022 India beat which country to win the 2022 SAFF U20 Championship title? Sri Lanka Bangladesh Canada Japan Sri Lanka Bangladesh Canada Japan ANSWER EXPLANATION DOWNLOAD EXAMIANS APP India beat Bangladesh 5-2 after extra time to clinch the 2022 SAFF U20 Championship title, at Kalinga Stadium in Bhubaneswar, Odisha.
Current Affairs - August 2022 India's first Indigenous Aircraft Carrier INS Vikrant handed over to whom? Indian Navy Indian Coast Guard Indian Air Force Indian Army Indian Navy Indian Coast Guard Indian Air Force Indian Army ANSWER EXPLANATION DOWNLOAD EXAMIANS APP India's first Indigenous Aircraft Carrier Vikrant, built by the Cochin Shipyard was handed over to the Indian Navy.
Current Affairs - August 2022 Which pharma company has completed trials for its intranasal Covid vaccine candidate? Dr Reddy's Bharat Biotech Serum Institute Biocon Dr Reddy's Bharat Biotech Serum Institute Biocon ANSWER EXPLANATION DOWNLOAD EXAMIANS APP Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.
EXAMIANS